Literature DB >> 2903554

Slow-acting antirheumatic drugs in chronic arthritis of childhood.

C Grondin1, P Malleson, R E Petty.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903554     DOI: 10.1016/0049-0172(88)90033-9

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  8 in total

Review 1.  Medical management of children with juvenile rheumatoid arthritis.

Authors:  J T Cassidy
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 2.  [The treatment of juvenile rheumatism: pharmacotherapy].

Authors:  F Weller; H-I Huppertz
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

3.  Methotrexate therapy in systemic-onset juvenile rheumatoid arthritis in Saudi Arabia: a retrospective analysis.

Authors:  W al-Sewairy; A al-Mazyed; S al-Balaa; S Bahabri
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Toxicity of antirheumatic and anti-inflammatory drugs in children.

Authors:  B Flatø; O Vinje; O Førre
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 5.  Juvenile rheumatoid arthritis: therapeutic perspectives.

Authors:  Ian C Chikanza
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis.

Authors:  D Caspi; D Fuchs; M Yaron
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 7.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

8.  Treatment of juvenile rheumatoid arthritis.

Authors:  Kwang Nam Kim
Journal:  Korean J Pediatr       Date:  2010-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.